ACW Insider Trading

Insider Ownership Percentage: 15.48%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Actinogen Medical Insider Trading History Chart

This chart shows the insider buying and selling history at Actinogen Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Actinogen Medical Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for ACW up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Actinogen Medical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/5/2024Steven GourlayInsiderIssued2,400,000A$0.03A$69,600.00
4/4/2024Malcolm McComasInsiderExpiry3,000,000A$0.03A$87,000.00
12/1/2023Nicki VasquezInsiderIssued5,500,000A$0.03A$170,500.00
11/27/2023Geoffrey BrookeInsiderExpiry4,900,000A$0.02A$112,700.00
9/11/2023Geoffrey BrookeInsiderIssued474,058A$0.03A$11,851.45
11/11/2022George MorstynInsiderExercise1,500,000A$0.10A$150,000.00
11/3/2022Steven GourlayInsiderBuy750,000A$0.13A$93,750.00
5/12/2022Steven GourlayInsiderBuy2,000,000A$0.06A$128,000.00
4/6/2022Steven GourlayInsiderIssued797,222A$0.14A$107,624.97
12/20/2021George MorstynInsiderIssued222,223A$0.14A$30,000.11
11/18/2021Geoffrey BrookeInsiderIssued2,500,000A$0.20A$500,000.00
See Full Table

SEC Filings (Institutional Ownership Changes) for Actinogen Medical (ASX:ACW)

9.22% of Actinogen Medical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, depression with cognitive impairment, Alzheimer's disease, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.
Read More on Actinogen Medical

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A


275,000 shs

Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Actinogen Medical?

Actinogen Medical's top insider shareholders include:
  1. Geoffrey Brooke (Insider)
  2. George Morstyn (Insider)
  3. Malcolm McComas (Insider)
  4. Nicki Vasquez (Insider)
  5. Steven Gourlay (Insider)
Learn More about top insider investors at Actinogen Medical.